Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Epigenomics Signs Licensing and Supply Agreement with Kindstar

Published: Friday, January 10, 2014
Last Updated: Thursday, January 09, 2014
Bookmark and Share
Agreement for Epigenomics’ Epi proLung® tissue assay for the Chinese market.

Epigenomics AG and Wuhan Kindstar Clinical Diagnostics Co. Ltd (Kindstar) have announced that both parties entered into a licensing and supply agreement for Epigenomics’ Epi proLung® tissue assay for the Chinese market.

Under the terms of the agreement Kindstar will commercialize the Epi proLung® assay for use in lung cancer diagnosis in China. Epigenomics will retain the responsibility to manufacture and supply the product and to provide support with respect to medical and regulatory considerations.

Noel Doheny, CEO of Epigenomics' US subsidiary, commented: "We are excited to enter into this agreement regarding our Epi proLung® tissue assay with Kindstar. The ability to leverage the established know-how and existing and well-functioning reference laboratory infrastructure of our new partner will provide a significant advantage for Epigenomics in the market introduction and technology roll-out of Epi proLung® in China. This agreement allows for a dual commercialization effort to apply Epigenomics' patented methods and its biomarker for lung cancer diagnosis in the Chinese market.”

“Epigenomics’ Epi proLung® assay fills an unmet need in current lung cancer diagnosis,” added Shiang Huang, M.D., CEO of Kindstar.

Huang continued, “We are very pleased to add Epi proLung® to the suite of cancer testing services we offer to Chinese physicians. We look forward to collaborating with Epigenomics on this assay and to the opportunity to expand our partnership on additional tests for the Chinese market.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Epigenomics Receives FDA Approval for Epi proColon®
Company has announced that the U.S. FDA has approved the Company’s lead product, Epi proColon®, blood-based colorectal cancer screening test.
Saturday, April 16, 2016
Epigenomics Enters Agreement With Biochain
Company has entered a strategic license and development agreement with BioChain on novel, blood-based lung cancer test for China.
Thursday, March 31, 2016
Epigenomics AG Announces 2014 Third Quarter Financial Results
Epigenomics AG has announced its financial results for the third quarter and the nine months 2014 ending September 30.
Tuesday, November 11, 2014
Polymedco Continues to Support Epi proColon(R)
Epigenomics' strategic commercialization partner Polymedco reiterates its commitment to support Epi proColon(R) in the United States.
Monday, November 03, 2014
Epigenomics AG Announces Non-exclusive Licensing Agreement with Companion Dx
Companion Dx has obtained rights to establish and commercialize a laboratory-developed test to detect colorectal cancer.
Friday, June 22, 2012
Epigenomics Successfully Optimized Assay Procedure for Cancer Screening Tests
Epigenomics AG has reached a milestone in completing the work on an optimized assay procedure for its blood-based cancer screening tests.
Tuesday, July 03, 2007
Epigenomics Demonstrates Feasibility of Convenient Blood Test for Lung
Epigenomics has announced positive data resulting from a clinical study as part of its lung cancer screening test development program.
Thursday, June 28, 2007
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
Human Stem Cells to Rapidly Generate Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Mechanism of Tuberculosis Infection
Researchers at UTSW Medical Center have identified a new way that tuberculosis bacteria get into the body, revealing a potential therapeutic angle to explore.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Eliminating Doubt in Criminal Investigations
New ASU certificate to help curb error, misunderstanding in the quest for justice.
Determination of 13 Organic Toxicants in Human Blood
Researchers have utilised liquid-liquid extraction coupling HPLC-MS/MS to identify and quantify organic toxicants in human blood.
A Novel Cell Culture Model For Forensic Biology Experiments
Researchers have developed a new cell culture model which provides an efficient research tool in forensic biology.
Rhino DNA Bank Aids Anti-Poaching Fight
At the University of Pretoria's Veterinary Genetics Laboratory (VGL) at Onderstepoort, Dr Cindy Harper and her team have developed a ground-breaking technique to collect and catalogue DNA from rhinos and rhino horns.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!